|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Funk GF, Karnell LH, Robinson RA, Zhen WK,
Trask DK and Hoffman HT: Presentation, treatment and outcome of
oral cavity cancer: A national cancer data base report. Head Neck.
24:165–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gowen GF and Desuto-Nagy G: The incidence
and sites of distant metastases in head and neck carcinoma. Surg
Gynecol Obstet. 116:603–607. 1963.PubMed/NCBI
|
|
4
|
Fletcher GH and Evers WT: Radiotherapeutic
management of surgical recurrences and postoperative residuals in
tumors of the head and neck. Radiology. 95:185–188. 1970.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen EE, Lingen MW and Vokes EE: The
expanding role of systemic therapy in head and neck cancer. J Clin
Oncol. 22:1743–1752. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kirita T, Ohgi K, Shimooka H, Yamanaka Y,
Tatebayashi S, Yamamoto K, Mishima K and Sugimura M: Preoperative
concurrent chemoradiotherapy plus radical surgery for advanced
squamous cell carcinoma of the oral cavity: An analysis of
long-term results. Oral Oncol. 35:597–606. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Freier K, Engel M, Lindel K,
Flechtenmacher C, Mühling J, Hassfeld S and Hofele C: Neoadjuvant
concurrent radiochemotherapy followed by surgery in advanced oral
squamous cell carcinoma (OSCC): A retrospective analysis of 207
patients. Oral Oncol. 44:116–123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohr C, Bohndorf W, Carstens J, Härle F,
Hausamen JE, Hirche H, Kimmig H, Kutzner J, Mühling J and Reuther
J: Preoperative radiochemotherapy and radical surgery in comparison
with radical surgery alone. A prospective, multicentric, randomized
DOSAK study of advanced squamous cell carcinoma of the oral cavity
and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac
Surg. 23:140–148. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klug C, Berzaczy D, Voracek M and Millesi
W: Preoperative chemoradiotherapy in the management of oral cancer:
A review. J Craniomaxillofac Surg. 36:75–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kirita T, Yamanaka Y, Imai Y, Yamakawa N,
Aoki K, Nakagawa Y, Yagyuu T and Hasegawa M: Preoperative
concurrent chemoradiotherapy for stages II–IV oral squamous cell
carcinoma: A retrospective analysis and the future possibility of
this treatment strategy. Int J Oral Maxillofac Surg. 41:421–428.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shirasaka T, Shimamoto Y, Ohshimo H,
Yamaguchi M, Kato T, Yonekura K and Fukushima M: Development of a
novel form of an oral 5-fluorouracil derivative (S-1) directed to
the potentiation of the tumor selective cytotoxicity of
5-fluorouracil by two biochemical modulators. Anticancer Drugs.
7:548–557. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harada K, Kawaguchi S, Supriatno S, Onoue
T, Yoshida Ha and Sato M: Combined effects of the oral
fluoropyrimidine anticancer agent, S-1 and radiation on human oral
cancer cells. Oral Oncol. 40:713–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harada H and Omura K: Preoperative
concurrent chemotherapy with S-1 and radiotherapy for locally
advanced squamous cell carcinoma of the oral cavity: Phase I trial.
J Exp Clin Cancer Res. 29:332010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Cancer Institute: Common
Terminology Criteria for Adverse Events v4.0 (CTCAE). http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfAccessed.
March 08–2016
|
|
15
|
Sobin LH and Wittekind C: TNM
classification of malignant tumours (6th). Wiley-Liss, Inc. New
York: 2002.
|
|
16
|
Yuasa K, Kawazu T, Nagata T, Kanda S,
Ohishi M and Shirasuna K: Computed tomography and ultrasonography
of metastatic cervical lymph nodes in oral squamous cell carcinoma.
Dentomaxillofac Radiol. 29:238–244. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuasa K, Kawazu T, Kunitake N, Uehara S,
Omagari J, Yoshiura K, Nakayama E and Kanda S: Sonography for the
detection of cervical lymph node metastases among patients with
tongue cancer: Criteria for early detection and assessment of
follow-up examination intervals. Am J Neuroradiol. 21:1127–1132.
2000.PubMed/NCBI
|
|
18
|
Gale N, Pilch BZ, Sindransky D, El Naggar
A, Westra W, Califano J, Johnson N and MacDonald DG: Epithelial
precursor lesions. In: World Health Organization Classification of
Tumors. Pathology and Genetics of Head and Neck Tumors. Barnes L,
Eveson JW, Reichart P and Sidransky D: IARC Press. (Lyon). 177–179.
2005.
|
|
19
|
Yamamoto E, Miyakawa A and Kohama G: Mode
of invasion and lymph node metastasis in squamous cell carcinoma of
the oral cavity. Head Neck Surg. 6:938–947. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eisenhauera EA, Therasseb P, Bogaertsc J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S and
Mooney M: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimosato Y, Oboshi S and Baba K:
Histological evaluation of effects of radiotherapy and chemotherapy
for carcinomas. Jpn J Clin Oncol. 1:19–35. 1971.
|
|
22
|
Slotman GJ, Doolittle CH and Glicksman AS:
Preoperative combined chemotherapy and radiation therapy plus
radical surgery in advanced head and neck cancer. Five-year results
with impressive complete response rates and high survival. Cancer.
69:2736–2743. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giralt JL, Gonzalez J, del Campo JM,
Maldonado J, Sanz X, Pamias J, Eraso A, Bescos S and Raspall G:
Preoperative induction chemotherapy followed by concurrent
chemoradiotherapy in advanced carcinoma of the oral cavity and
oropharynx. Cancer. 89:939–945. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mücke T, Konen M, Wagenpfeil S, Kesting
MR, Wolff KD and Hölzle F: Low-dose preoperative chemoradiation
therapy compared with surgery alone with or without postoperative
radiotherapy in patients with head and neck carcinoma. Ann Surg
Oncol. 18:2739–2747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iguchi H, Kusuki M, Nakamura A, Nishiura
H, Kanazawa A, Takayama M, Sunami K and Yamane H: Concurrent
chemoradiotherapy with pirarubicin and 5-fluorouracil for
resectable oral and maxillary carcinoma. Acta Otolaryngol Suppl.
554:55–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Numico G, Benasso M, Vannozzi MO, Merlano
M, Rosso R, Viale M and Esposito M: Hydration regimen and
hematological toxicity of a cisplatin-based chemotherapy regimen.
Clinical observations and pharmacokinetic analysis. Anticancer Res.
18:1313–1318. 1998.PubMed/NCBI
|
|
27
|
Harada H, Omura K, Tomioka H, Nakayama H,
Hiraki A, Shinohara M, Yoshihama Y and Shintani S: Multicenter
phase II trial of preoperative chemoradiotherapy with S-1 for
locally advanced oral squamous cell carcinoma. Cancer Chemother
Pharmacol. 71:1059–1064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsukuda M, Ishitoya J, Mikami Y, Matsuda
H, Horiuchi C, Taguchi T, Satake K, Kawano T, Takahashi M and
Nishimura G: Analysis of feasibility and toxicity of concurrent
chemoradiotherapy with S-1 for locally advanced squamous cell
carcinoma of the head and neck in elderly and/or cases with
comorbidity. Cancer Chemother Pharmacol. 64:945–952. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsukuda M, Kida A, Fujii M, Kono N,
Yoshihara T, Hasegawa Y and Sugita M: Chemotherapy Study Group of
Head and Neck Cancer: Randomized scheduling feasibility study of
S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br
J Cancer. 93:884–889. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyawaki A, Hijioka H, Ikeda R, Ishida T,
Nozoe E and Nakamura N: Analysis of the outcome of concurrent
neoadjuvant chemoradiotherapy with S-1 compared to super-selective
intra-arterial infusion for oral squamous cell carcinoma. Oncol
Lett. 3:995–1001. 2012.PubMed/NCBI
|
|
31
|
Nomura T, Murakami R, Toya R, Teshima K,
Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y and Ota K:
Phase II study of preoperative concurrent chemoradiation therapy
with S-1 in patients with T4 oral squamous cell carcinoma. Int J
Radiat Oncol Biol Phys. 76:1347–1352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bernier J, Domenge C, Ozashin M,
Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P,
Rolland F, Bolla M, et al: Postoperative irradiation with or
without concomitant chemotherapy for locally advanced head and neck
cancer. N Engl J Med. 350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pignon JP, Bourhis J, Domenge C and
Designé L: Chemotherapy added to locoregional treatment for head
and neck squamous-cell carcinoma: Three meta-analyses of updated
individual data. MACH-NC collaborative group. Meta-analysis of
chemotherapy on head and neck cancer. Lancet. 355:949–955. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Licitra L, Grandi C, Guzzo M, Mariani L,
Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G,
Molinari R and Cantù G: Primary chemotherapy in resectable oral
cavity squamous cell cancer: A randomized controlled trial. J Clin
Oncol. 21:327–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yanamoto S, Yamada S, Takahashi H,
Yoshitomi I, Kawasaki G, Ikeda H, Minamizato T, Shiraishi T, Fujita
S and Ikeda T: Clinicopathological risk factors for local
recurrence in oral squamous cell carcinoma. Int J oral Maxillofac
Surg. 41:1195–1200. 2012. View Article : Google Scholar : PubMed/NCBI
|
